Articles Index

Celebrex Rebounds After Wall Street Journal Report
Follow-up analysis indicates there is no direct causal relationship between Celebrex use and the 10 deaths originally associated with the drug in a Wall Street Journal report.

Celebrex Causes Concern
Two reports are causing concern over Celebrex.

Canadian Study: Is Celebrex The Safest Anti-Inflammatory Drug?
Studies are being conducted to determine what non-steroidal anti-inflammatory drug (NSAIDS) or COX-2 inhibitor is the safest. Celebrex appears to have lower risk of congestive heart failure.

Celebrex And Vioxx Set To Battle
Celebrex and Vioxx compete as new drugs for the treatment of arthritis.

Celebrex (Celecoxib) Approved By FDA
On December 31, 1998, the FDA approved Celebrex (celecoxib) for the relief of the signs and symptoms of osteoarthritis and adult rheumatoid arthritis.

Celebrex (Celecoxib) Recommended For Approval
On December 1, 1998, the FDA advisory panel unanimously recommended the approval of Celebrex, generically known as celecoxib, for the treatment of osteoarthritis and rheumatoid arthritis.

Second, Replicate Study Favors Celebrex
Study compares Celebrex and Vioxx and their cardiovascular side effects.